Company-wide revenue
Reported revenue in 2021 ¥162.6B Reported revenue in 2025 ¥241.24B
- growth amount
- +¥78.63B
- growth annualized
- +10.4%
- growth total
- +48.4%
Japanese company profile · 2590
DyDo GROUP HOLDINGS,INC.
In its FY2025 public filing, DyDo GROUP HOLDINGS,INC. reports Domestic Beverages Business, Overseas Beverages Business, Pharmaceuticals-related Business, Food Products, and 1 other reported businesses. The page shows business-level revenue and profit where the source disclosures support comparison.
Original Japanese company name: ダイドーグループホールディングス株式会社
English company name recorded in Japan's EDINET filer data. English company name source
Reported company-wide figures
What does this company do?
What does this company do?
DyDo GROUP HOLDINGS,INC.'s largest reported business by revenue in FY2025 was Domestic Beverages Business.
The business with the highest reported segment profit in FY2025 was Overseas Beverages Business.
FY2025 · fiscal year ended January 2026 View original filing ↗ The source document may be in Japanese.
Business structure
How does it make money?
| Business | Sales | Revenue share | Operating profit |
|---|---|---|---|
| Domestic Beverages Business | ¥142.65B ↗ | 59.1% | −¥2.28B ↗ |
| Overseas Beverages Business | ¥65.34B ↗ | 27.1% | ¥7.55B ↗ |
| Food Products | ¥19.57B ↗ | 8.1% | ¥487M ↗ |
| Pharmaceuticals-related Business | ¥13.44B ↗ | 5.6% | ¥829M ↗ |
| Orphan Drugs Business | ¥606M ↗ | 0.3% | −¥321M ↗ |
All values are in Japanese yen (JPY). No currency conversion is applied. FY2025 · fiscal year ended January 2026. Revenue and profit are shown only where the filing and data support a comparison.
Original Japanese label
- Domestic Beverages Business
- 国内飲料事業
- Overseas Beverages Business
- 海外飲料事業
- Pharmaceuticals-related Business
- 医薬品関連事業
- Food Products
- 食品事業
- Orphan Drugs Business
- 希少疾病用医薬品事業
- Sales
- 売上高
- Operating profit
- 営業利益
Original Japanese label
- Domestic Beverages Business
- 国内飲料事業
- Overseas Beverages Business
- 海外飲料事業
- Pharmaceuticals-related Business
- 医薬品関連事業
- Food Products
- 食品事業
- Orphan Drugs Business
- 希少疾病用医薬品事業
- Sales
- 売上高
- Operating profit
- 営業利益
Reported Sales by business over time
Reported Sales by business over time
| Fiscal year | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Domestic Beverages Business | ¥118.08B | ¥109.77B | ¥153.62B | ¥147.52B | ¥142.65B |
| Overseas Beverages Business | ¥12.78B | ¥18.91B | ¥26.44B | ¥56.26B | ¥65.34B |
| Pharmaceuticals-related Business | ¥11.13B | ¥12.52B | ¥12.96B | ¥13.12B | ¥13.44B |
| Food Products | ¥21.16B | ¥19.57B | ¥20.7B | ¥20.65B | ¥19.57B |
| Orphan Drugs Business | — | — | — | ¥8M | ¥606M |
All amounts are in Japanese yen (JPY). Each figure links to the original Japanese filing. Blank cells indicate no comparable figure was disclosed. Business figures may not add up to consolidated figures.
What is growing?
What is growing?
Business revenue growth
Overseas Beverages Business
Reported revenue in 2021 ¥12.78B Reported revenue in 2025 ¥65.34B
- growth amount
- +¥52.56B
- growth annualized
- +50.4%
- growth total
- +411.4%
View original filing
Pharmaceuticals-related Business
Reported revenue in 2021 ¥11.13B Reported revenue in 2025 ¥13.44B
- growth amount
- +¥2.3B
- growth annualized
- +4.8%
- growth total
- +20.7%
View original filing
Overseas Beverages Business
Reported profit margin in 2022 -5.8%
Reported profit margin in 2025 +11.6%
- growth margin points
- +17.3
View original filing
Pharmaceuticals-related Business
Reported profit margin in 2022 +2.8%
Reported profit margin in 2025 +6.2%
- growth margin points
- +3.4
View original filing
This describes a reported period; it is not a forecast.
What has changed?
What has changed?
Not disclosed or not safely comparable in the available filings.
Source
Public filing
FY2025 · fiscal year ended January 2026
The source document may be in Japanese.
Filing ID: S100XYDT
View original filing ↗Ask about this company
Ask about this company
The source document may be in Japanese.